Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ACRV: Acrivon Therapeutics, Inc. Common Stock Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ACRV
The Story
ACRV
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-84.1%
Financially safe
Stretched
Debt / equity
0.03×
Interest coverage
0.0×
Current ratio
8.98×
Acrivon Therapeutics, Inc. Common Stock
ACRV
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Acrivon Therapeutics, Inc. Common Stock
ACRV
NASDAQ
·
USD
·
Closed
$1.50
−1.32%
$1.50
−$0.02 (1.32%)
52W Range
13th
pctl
Volume
1.12×
avg
Mkt Cap
64.20M
USD
P/E
-0.8
TTM
Div Yield
–
ann
52W Range
13th
pctl
Volume
1.12×
avg
Market Cap
64.20M
USD
P/E Ratio
-0.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings